Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Inflammatory Markers in ph Negative Myeloproliferative Neoplasms: Impact on Outcome and Response to Therapy. Multicenter Retro-prospective Observational Study. The INFLA-ME (INFLAmmation in Myeloproliferative Disease) Study.

NCT05553873 is registered in ClinicalTrials.gov with University of Milano Bicocca as lead sponsor.

NCT NCT05553873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05553873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Inflammatory Markers in ph Negative Myeloproliferative Neoplasms: Impact on Outcome and Response to Therapy. Multicenter Retro-prospective Observational Study. The INFLA-ME (INFLAmmation in Myeloproliferative Disease) Study.
Lead sponsor
University of Milano Bicocca
Phase
Observational
Overall status
Recruiting
Start date
September 8, 2022
Completion date
December 31, 2026
Enrollment
500 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory markers, myeloproliferative disease